Sponsor Pipeline

Shunda Du Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07639138 Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC Hepatocellular Carcinoma (HCC) Recruiting
Disease Areas
Liver Cancer (1)
Get alerts when Shunda Du's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free